Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.43 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15834924 | 1.00 | TP53 (0.44) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL13635791 | 1.00 | TP53 (0.44) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL30751933 | 0.90 | TP53 (0.42) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6690380 | 0.88 | TP53 (0.40) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6694298 | 0.88 | TP53 (0.40) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL1261744 | 0.86 | TP53 (0.50) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| SCHEMBL18211012 | 0.86 | TP53 (0.50) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| Ammonia Solution, Strong SCHEMBL8858522 | 0.83 | TP53 (0.47) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| Ammonia Solution, Strong SCHEMBL8858520 | 0.83 | TP53 (0.47) | TP53SLC7A5GABRR1RNPEPCYP1A2 | |
| SCHEMBL24287053 | 0.79 | TP53 (0.38) | TP53SLC7A5SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4641061-A1 | OIL-WELL METAL PIPE | NIPPON STEEL CORPORATION (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4570255-A1 | SPORICIDAL ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | Silva, Renata Moisés Iwamizu (BR) | 2025-06-18 | — | — | EP | disclosed |
| US-20250188376-A1 | SUSTAINABLE AVIATION FUELS | SARTEC CORPORATION | 2025-06-12 | — | — | US | disclosed |
| WO-2024135464-A1 | OIL-WELL METAL PIPE | 日本製鉄株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024031162-A1 | SPORICIDAL ANTIMICROBIAL COMPOSITIONS AND USES THEREOF | DA SILVA, Tasso Pereira (BR) | 2024-02-15 | — | — | WO | disclosed |
| CN-115253881-A | 2-methyl isopropyl butyrate adding device for fruit essence production | 金溪县鑫润香料实业有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-112266809-A | Base oil for refrigerator oil, and working fluid composition for refrigerator | 珠海格力节能环保制冷技术研究中心有限公司 | 2021-01-26 | — | — | CN | disclosed |
| CN-110799179-A | Solid composition comprising iodine reagent and sodium chloride with improved water solubility and antiviral and antibacterial composition for eye, oral cavity, nasal cavity or inhalation comprising aqueous solution thereof | 富陆凯米有限责任公司 | 2020-02-14 | — | — | CN | disclosed |
| EP-2768873-A2 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.r.l. (IT) | 2014-08-27 | — | — | EP | disclosed |
| WO-2013057026-A2 | CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2013-04-25 | — | — | WO | disclosed |
| US-20020176838-A1 | 2-,5-,6-,7-,8-substituted oct-2-en-4-ones | GIVAUDAN SA | 2002-11-28 | — | — | US | disclosed |
| US-6465426-B2 | ACYLATION | ELI LILLY AND COMPANY | 2002-10-15 | — | — | US | disclosed |
| US-20020082199-A1 | Insoluble insulin compositions | BRADER MARK LAURENCE (US) | 2002-06-27 | — | — | US | disclosed |
| EP-1196446-A1 | PROTAMINE-FREE INSOLUBLE ACYLATED INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 2002-04-17 | — | — | EP | disclosed |
| US-20010036916-A1 | Insoluble insulin compositions | BRADER MARK LAURENCE (US) | 2001-11-01 | — | — | US | disclosed |
| EP-1149820-A1 | 2-,5-,6-,7-,8-substituted oct-2-ene-4-one | Givaudan SA (CH) | 2001-10-31 | — | — | EP | disclosed |
| US-6268335-B1 | MICROCRYSTAL COMPRISING (A) DERIVIATED INSULIN, DERIVIATED INSULIN ANALOGS, OR DERIVIATED PROINSULINS; (B) A COMPLEXING COMPOUND; (C) A HEXAMER-STABILIZING COMPOUND; AND (D) A DIVALENT METAL CATION. | ELI LILLY AND COMPANY | 2001-07-31 | — | — | US | disclosed |
| WO-2001000675-A1 | PROTAMINE-FREE INSOLUBLE ACYLATED INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 2001-01-04 | — | — | WO | disclosed |
| EP-0925792-A2 | Insoluble compositions for controlling blood glucose | ELI LILLY AND COMPANY (US) | 1999-06-30 | — | — | EP | disclosed |
| EP-0911035-A2 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-04-28 | — | — | EP | disclosed |